Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
Date:4/30/2008

XI'AN, China, April 30 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it will release financial results for their first quarter ended March 31 on Thursday, May 15, 2008, after the US markets close. Huifeng's earnings release and related materials will be available on the investor's page of its website, http://www.hfgb.cn .

About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

For more information, please contact:

Dan Carlson, Primary Capital LLC

Tel: +1-415-460-1165

Email: DCarlson@PrimaryLLC.com


'/>"/>
SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
2. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
3. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. 3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
6. ATS Medical Announces First Quarter 2008 Earnings Release Date and Conference Call
7. Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
8. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
9. Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T.
10. Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call
11. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire-FirstCall/--Sigma-AldrichCorporation(Nas...eonTuesday,December1stat1:45PMGMTinLondon,7:45AMUS...stovertheInternetavailableat http://inve s tor....st"icontoaccessthisfile. ,, AboutSigma-Aldric...ologycompany.Itschemicalandbiochemicalproductsandk...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq...ingandcommercializingnovelpainmanagementtherapies,...ExecutiveOfficer,isscheduledtopresentatthe21stAnnu...r1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork....lOfficer,willbeavailabletorespondtoquestionsduring...
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc....cHealth,sExecutiveChairman,willpresentatthe21stAnn...Tuesday,December1,2009at10:00a.m.ET. ,, Toacces...ation,visittheInvestorRelationssectionofGenomicHea...Pleaseconnecttothewebsiteatleast15minutespriortoth...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...sconsin may have received only three of the 35 Mid...first quarter of 2006, but one local observer isn,...eek said 35 Midwestern companies attracted a total...hree Wisconsin companies with at least $7 million....ting venture capital, some view this as the contin...
...a company TDS, also the corporate parent of U.S. C...re $1 billion, an increase over results from last ...lems. , ,Net income for the quarter was $41.5 mill... year ago. , ,TDS said in November 2005 it would h...through 2005. The process delayed the companys ann...
.... - A former chief legal counsel to former Gov. T...from a legal standpoint with Gov. Jim Doyle,s Apri..., a partner in the Madison office of Michael Best...the authority to direct state departments to spend...nor issued an executive order directing the Depart...
Other Biology Technology:Angel investing should lead to more venture funding, Ward says 2Angel investing should lead to more venture funding, Ward says 3Former Thompson lawyer comments on Doyle stem cell executive order 2Former Thompson lawyer comments on Doyle stem cell executive order 3
(Date:11/24/2009)...vember 24, 2009) New research on bacterial commun... reveals predictable temporal patterns, suggesting...rkers for monitoring climate change in the polar r...ceedings of the National Academy of Sciences Earl... six rivers shifted synchronously over time, corre...
(Date:11/23/2009)...s. November 23, 2009 Applied mathematicians diss...lancifolia ), a characteristic long leaf with a sa...s along the edges. The simple cause of the lily,s ...nding during differential growthwas revealed by us...ibbons. , Haiyi Liang, a postdoctoral student at...
(Date:11/23/2009)...rrent research suggests that a common oral bacteri... report by Nichols et al, "Unique Lipids from a Co... Ligands Capable of Enhancing Autoimmunity," appea...rnal of Pathology . , Multiple sclerosis (MS), a... and spinal cord, affects nearly 1 in 700 people i...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Recession Stressful for Many Kids Toughest on Poor and Uninsured 52636 1Recession Stressful for Many Kids Toughest on Poor and Uninsured 52636 2Recession Stressful for Many Kids Toughest on Poor and Uninsured 52636 3IDEXX Laboratories Announces Second Quarter Results 52634 1IDEXX Laboratories Announces Second Quarter Results 52634 2IDEXX Laboratories Announces Second Quarter Results 52634 3IDEXX Laboratories Announces Second Quarter Results 52634 4IDEXX Laboratories Announces Second Quarter Results 52634 5IDEXX Laboratories Announces Second Quarter Results 52634 6IDEXX Laboratories Announces Second Quarter Results 52634 7IDEXX Laboratories Announces Second Quarter Results 52634 8IDEXX Laboratories Announces Second Quarter Results 52634 9IDEXX Laboratories Announces Second Quarter Results 52634 10IDEXX Laboratories Announces Second Quarter Results 52634 11IDEXX Laboratories Announces Second Quarter Results 52634 12IDEXX Laboratories Announces Second Quarter Results 52634 13IDEXX Laboratories Announces Second Quarter Results 52634 14IDEXX Laboratories Announces Second Quarter Results 52634 15IDEXX Laboratories Announces Second Quarter Results 52634 16IDEXX Laboratories Announces Second Quarter Results 52634 17IDEXX Laboratories Announces Second Quarter Results 52634 18IDEXX Laboratories Announces Second Quarter Results 52634 19IDEXX Laboratories Announces Second Quarter Results 52634 20IDEXX Laboratories Announces Second Quarter Results 52634 21IDEXX Laboratories Announces Second Quarter Results 52634 22Teamwork Technology and Coordinated Care Improve Outcomes and Lower Costs 52633 1Teamwork Technology and Coordinated Care Improve Outcomes and Lower Costs 52633 2Teamwork Technology and Coordinated Care Improve Outcomes and Lower Costs 52633 3
...genetic analysis of its kind to date for bipolar d...alance of sodium and calcium in brain cells. Resea... of Mental Health, part of the National Institutes...der and variation in two genes that make component... into and out of cells, including neurons. , "A ...
...ll., Aug. 15 Zebra,Technologies Corporation (Nasd...to a five-year, $100 million revolving credit faci...acility for working capital and general,corporate ...s. The,revolving credit facility has a $100 millio...rease the facility up to a total of $200 million s...
...arnegie Mellon University researchers are urging c...trail of dangerous carbon emissions that are respo...ats. , Because there is no univers...footprint, dozens of carbon calculators have sprun...g confusion and inaccurate information. In additio...
Other Biology News:Largest study of its kind implicates gene abnormalities in bipolar disorder 2Zebra Technologies Enters Into Revolving Credit Agreement to Support Company Growth 2Carnegie Mellon urges industry to broaden carbon footprint calculations 2
Agar from Calbiochem
luciferase Assay Kit, Bright-Glo from Promega
LHC BASAL MEDIUM from Invitrogen
Immobilized E. coli Lysate from Pierce Biotechnology, Inc.
Biology Products: